Addison Advisors LLC Acquires 115 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Addison Advisors LLC increased its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 27.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 535 shares of the exchange traded fund’s stock after purchasing an additional 115 shares during the quarter. Addison Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $48,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of XBI. FMR LLC lifted its holdings in SPDR S&P Biotech ETF by 13.6% in the third quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock worth $686,000 after buying an additional 830 shares during the period. Ameritas Advisory Services LLC lifted its holdings in SPDR S&P Biotech ETF by 11.9% in the fourth quarter. Ameritas Advisory Services LLC now owns 10,684 shares of the exchange traded fund’s stock worth $962,000 after buying an additional 1,137 shares during the period. Beaton Management Co. Inc. purchased a new stake in SPDR S&P Biotech ETF in the third quarter worth about $212,000. Van ECK Associates Corp purchased a new stake in SPDR S&P Biotech ETF in the fourth quarter worth about $1,497,000. Finally, Hollow Brook Wealth Management LLC lifted its holdings in SPDR S&P Biotech ETF by 4.9% in the third quarter. Hollow Brook Wealth Management LLC now owns 21,669 shares of the exchange traded fund’s stock worth $2,141,000 after buying an additional 1,003 shares during the period.

SPDR S&P Biotech ETF Price Performance

Shares of XBI opened at $88.69 on Wednesday. SPDR S&P Biotech ETF has a one year low of $81.14 and a one year high of $105.47. The company has a 50-day simple moving average of $91.14 and a two-hundred day simple moving average of $95.92. The firm has a market capitalization of $6.76 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.